Overcoming resistance to BRAF<sup>V600E</sup> inhibition in melanoma by deciphering and targeting personalized protein network alterations.

Vasudevan, S; Flashner-Abramson, E; Alkhatib, Heba; Roy Chowdhury, Sangita; Adejumobi, I A; Vilenski, D; Stefansky, S; Rubinstein, A M; Kravchenko-Balasha, N

Overcoming resistance to BRAF^V600E inhibition in melanoma by deciphering and targeting personalized protein network alterations.

Vasudevan, S; Flashner-Abramson, E; Alkhatib, Heba; Roy Chowdhury, Sangita; Adejumobi, I A; Vilenski, D; Stefansky, S; Rubinstein, A M; Kravchenko-Balasha, N.

Vasudevan S; The Institute of Biomedical and Oral Research, Hebrew University of Jerusalem, Jerusalem, Israel.
Flashner-Abramson E; The Institute of Biomedical and Oral Research, Hebrew University of Jerusalem, Jerusalem, Israel.
Alkhatib H; The Institute of Biomedical and Oral Research, Hebrew University of Jerusalem, Jerusalem, Israel.
Roy Chowdhury S; The Institute of Biomedical and Oral Research, Hebrew University of Jerusalem, Jerusalem, Israel.
Adejumobi IA; The Institute of Biomedical and Oral Research, Hebrew University of Jerusalem, Jerusalem, Israel.
Vilenski D; The Institute of Biomedical and Oral Research, Hebrew University of Jerusalem, Jerusalem, Israel.
Stefansky S; The Institute of Biomedical and Oral Research, Hebrew University of Jerusalem, Jerusalem, Israel.
Rubinstein AM; The Institute of Biomedical and Oral Research, Hebrew University of Jerusalem, Jerusalem, Israel.
Kravchenko-Balasha N; The Institute of Biomedical and Oral Research, Hebrew University of Jerusalem, Jerusalem, Israel. natalyk@ekmd.huji.ac.il.

NPJ Precis Oncol ; 5(1): 50, 2021 Jun 10.

Article en En | MEDLINE | ID: mdl-34112933

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2021 Tipo del documento: Article